Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record now shows revision v3.5.4, replacing the previous v3.5.3. This signals a minor update to the page content rather than a change to the study details.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a maintenance/version bump without altering the displayed study details.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded a citation to iRECIST guidelines (Lancet Oncology 2017) in Publications and removed the Lancet Oncology 2019 erratum note from the same reference.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check86 days agoChange DetectedUpdated the iRECIST citation to revision v3.4.3, replacing the previous v3.4.2 citation.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.